At the peak of the COVID-19 pandemic, clinical study monitors and patients were restricted from sites. Sponsors and CROs had to reassess
how to keep trials on track while initiating and prioritising new trials related to COVID-19. Rik van Mol at Veeva outlines how remote
monitoring is needed to keep clinical trials running, as COVID-19 forced hundreds of trials to stall.